Mariateresa Giuliano

universita della campania vanvitelli

H指数:24

被引数:2,300

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive/HER2-negative BC patients: results from the multicenter PALMARES-2 study

真实世界中一线帕博西利、瑞博西利或阿贝西利联合内分泌治疗在晚期HR阳性/HER2阴性乳腺癌患者中的疗效比较：多中心PALMARES-2研究的结果

Annals of Oncology

IF65.4

2025-04-080

PRE

Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671)

ramucirumab联合卡铂和紫杉醇治疗未治疗的转移性胸腺癌的疗效和安全性: RELEVENT II期试验 (NCT03921671)

ANNALS OF ONCOLOGY

IF65.4

2024-09-012

Proto, C.; Ganzinelli, M.; Manglaviti, S.; Imbimbo, M.; Galli, G.; Marabese, M.; Zollo, F.; Alvisi, M. F.; Perrino, M.; Cordua, N.; Borea, F.; de Vincenzo, F.; Chella, A.; Cappelli, S.; Pardini, E.; Ballatore, Z.; Lucarelli, A.; Ambrosini, E.; Giuliano, M.; Pietroluongo, E.; Mulargiu, C.; Fabbri, A.; Prelaj, A.; Occhipinti, M.; Brambilla, M.; Mazzeo, L.; Beninato, T.; Vigorito, R.; Ruggirello, M.; Greco, F. G.; Calareso, G.; Miliziano, D.; Rulli, E.; De Simone, I.; Torri, V.; de Braud, F. G. M.; Pasello, G.; De Placido, P.; Berardi, R.; Petrini, I.; Zucali, P.; Garassino, M. C.; Lo Russo, G.

Bridging the gap between real-world studies (RWSs) and randomized controlled trials (RCTs) of 1st-line palbociclib plus aromatase inhibitors (P plus AI) in hormone receptor-positive (HR+)/HER2-negative(-) metastatic breast cancer (mBC)

弥合真实世界研究（RWSs）与1线帕博西利联合芳香化酶抑制剂（P plus AI）在激素受体阳性（HR+)/人表皮生长因子受体2阴性(-)转移性乳腺癌（mBC）中的随机对照试验（RCTs）之间的差距

ANNALS OF ONCOLOGY

IF65.4

2024-09-010

PRE

Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial

ANNALS OF ONCOLOGY

IF65.4

2023-10-012